Programme - ophthalmology-futures.com€¦ · 3 Ophthalmology Futures Asia Forum 2017Singapore...

Asia Forum Singapore 2017

w ophthalmology-futures.com | e [email protected] | t +44 (0) 207 099 6663 | m +44 (0) 7984 921 734

ProgrammeWednesday 1st March 2017The Pan Pacific Hotel, Singapore

“This is one of the greatest conferences to come to. It.s both small enough that we can really meet with people but large enough that it attracts the people we want to meet with.”

Laurence Marsteller Salutaris Medical Devices

Ophthalmology Futures Asia Forum 2017 Singapore 2

Ophthalmology Futures Asia Forum 2017

Dear Colleagues,

Welcome to Ophthalmology Futures Asian Forum 2017. After 5 successful European Forums and our inaugural Asian Forum in Tokyo in 2014, we are delighted to host our second Asian Forum in Singapore.

Each Forum aims to present a new perspective with regard to innovation in the ophthalmic sector. This forum comes at a particularly exciting time for innovation in Ophthalmology and with a timely focus on innovation in Asia.

We would like to thank our advisory board, programme committee, corporate presenters, sponsors and eminent faculty for their invaluable support and assistance. We hope that you will enjoy the format and gain inspiration from the company presentations and panel discussions. We will endeavour to make the meeting as interactive as possible.

The Ophthalmology Futures Team

Vision Futures Limited, London, UK registered in England No: 8125858

Ophthalmology Futures Asia Forum 2017 Singapore3

08:00 - 08:45 > Registration

08:45 - 09:00 > Introduction and welcome Keith Barton Consultant Ophthalmologist, Moorfields Eye Hospital, UK

Clement Tan Head and Senior Consultant at the Department of Ophthalmology, National University Hospital, Singapore

09:00 - 09:30 > Beyond anti-VEGFs: Surviving the injections Co-chairs: Adnan Tufail Consultant Ophthalmologist, Moorfields Eye Hospital, UK

Tien Yin Wong Medical Director, Singapore National Eye Center, Singapore

Panellists: Caroline Chee Head and Senior Consultant for Surgical Retina, National University Hospital, Singapore

Yan Cheng Chief Medical Officer of Global Clinical Research, Chengdu Kanghong Biotechnology Co. Ltd., China

Chuck Holmes Director, Strategic Marketing, Bayer, USA

Timothy Lai Honorary Clinical Associate Professor, Department of Ophthalmology and Visual Sciences, Coordinator of the Medical Retina and Uveitis Service, Hong Kong Eye Hospital, China

Lin Lu Professor and Director, Fundus Disease Center, Zhongshan Ophthalmic Center, Sun Yat-sen University, China

Paisan Ruamviboonsuk Assistant Director, Rajavithi Hospital and President of the Royal College of Ophthalmologists, Thailand

Naveed Shams Head of Global Research and Development, Chief Scientific Officer, Senior Corporate Officer, Santen Pharmaceutical Co. Ltd., USA

Xiaoxin Li Professor and Director, People Eye Research Institute, Peking University and Director, Ministry of Health State Key Laboratory for Trauma and Repairing, China

Eli Zangvil Global Brand Medical Director, Novartis, Switzerland

09:30 - 10:50 > Company presentations 1Chair: Chelvin Sng Consultant and Assistant Professor, National University Hospital, Singapore

09:30 - 09:40 Company: OccuRx Darren Kelly Chief Executive Officer, OccuRx

09:40 - 09:50 Company: Guangzhou Biotechnology Company Rajvardhan Azad Consultant Viteroretinal Surgeon and ROP Specialist, Bharti Eye Hospital

09:50 - 10:00 Company: Abyss Processing Ptd. Ltd. Michael Girard Assistant Professor, National University of Singapore

10:00 - 10:10 Company: Cassini B.V Tom Dunlap Chairman, Cassini B.V

10:10 - 10:20 Company: InfiniteVision Optics SAS Carsten Laue Chief Executive Officer, InfiniteVision Optics SAS

10:20 - 10:30 Company: SAV-IOL SA Andre Mermoud Clinique de Montchoisi

10:30 - 10:40 Company: Z Lenz LLC Paul Marius Beer Chief Executive Officer, Z Lens LLC

10:40 - 10:50 Discussion

Ophthalmology Futures Asia Forum 2017 programme


10:50 - 11:20 > Developing and taking a new idea to market Co-chairs: Boris Malyugin Professor of Ophthalmology, Department of Cataract and Implant Surgery, Deputy Director

General, S. Fyodorov Eye Microsurgery State Instituition, Russia

Steven Myint Adjunct Professor at Duke-National University Singapore, Center for Technology, Enterprise and Development, Singapore

Panellists: Jonathan Agmon Partner, Head Singapore Office, Soroker Agmon Nordman, Singapore

Danny Belkin Technology Development and Commercialisation Director, Singapore Eye Research Institute, Singapore

Duncan Bishop Programme Director, Cambridge Consultants Ltd., UK

John Marshall Professor of Ophthalmology, Institute of Ophthalmology, University College London, UK

Thong Yuen Poon Advisor and Mentor, Venturecraft Group, Zicom MedTacc Pte. Ltd., Singapore

Leopold Schmetterer Professor of Ophthalmology and Head of Ocular Imaging, Singapore Eye Research Institute, Singapore

Theodore Tan Managing Director, The Biofactory, Singapore

11:50 - 12:30 > The Asian investment climate Co-Chairs: Steven Fang Executive Director and Chief Executive Officer, Capbridge, Singapore

Fay Xing Partner, Wuxi Healthcare Ventures, China

Panellists: Takashi Hibi Head of Global Business Development at Santen Pharmaceutical Co. Ltd., Japan

XiangQian Lin Founder and General Partner, ESCO Ventures, Singapore

Ken Noonan Chief Executive Officer, Lightstone Ventures Pte. Ltd., Singapore

Jeong Shing Ong Investment Director, VentureCraft, Singapore

12:30 - 12:50 > Trends in glaucoma devices and drug delivery in Asia 1: The buyers aspirations

Co-chairs: Keith Barton Consultant Ophthalmologist, Moorfields Eye Hospital, UK

Ningli Wang Professor and Director, Beijing Tongren Eye Center, Director, Beijing Eye Research Institute, Director, Beijing College of Ophthalmology, Capital Medical University, and Secretary of the Party Committee and Vice President, Beijing Tongren Hospital, China

Panellists: Chelvin Sng Consultant and Assistant Professor, National University Hospital, Singapore

Xinghuai Sun Professor and President, Eye and ENT Hospital, Fudan University and Director, Department of Ophthalmology, Shanghai Medical School, Fudan University, China

Tetsuya Yamamoto Professor and Chairman, Department of Ophthalmology and Director of Glaucoma Service, Gifu University School of Medicine, Japan

Mingbin Yu Vice President, Sun Yat-Sen University and Professor, Glaucoma Service, Zhongshan Ophthalmic Center, China

>>

12:50 - 13:10 > Trends in glaucoma devices and drug delivery in Asia 2: The sellers respond

Co-chairs: Keith Barton Consultant Ophthalmologist, Moorfields Eye Hospital, UK

Ningli Wang Professor and Director, Beijing Tongren Eye Center, Director, Beijing Eye Research Institute, Director, Beijing College of Ophthalmology, Capital Medical University and, Secretary of the Party Committee and Vice President, Beijing Tongren Hospital, China

Panellists: Glen Burgess, Managing Director Asia-Pacific, Ivantis Inc., Australia

Peter England Global Product Director, Surgical Glaucoma, Alcon, USA

Miriam Kenrick Senior Director, International Strategic Marketing, Ophthalmology (Glaucoma), Allergan, UK

Mike Neilon Vice President, Glaukos Corporation, USA

Naveed Shams Head of Global Research and Development, Chief Scientific Officer, Senior Corporate Officer, Santen Pharmaceutical Co. Ltd., USA

13:10 - 14:00 > Lunch

14:00 - 14:30 > Market access for femtosecond laser cataract surgery and premium IOLs in Asia

Co-chairs: David Chang Clinical Professor, University of California, San Francisco, USA

Soon-Phaik Chee Senior Consultant and Head of Cataract and Ocular Inflammation and Immunology Service, Singapore National Eye Center, Singapore

Panellists: Miguel Bernabeu Global Head Market Access, Pricing and HEOR, Alcon Laboratories, Inc., USA

Danying Zheng Professor, Deputy Director, Department of Ophthalmology and Optometry, Zhongshan Ophthalmic Center, Sun Yat-Sen University, China

Boris Malyugin Professor of Ophthalmology, Department of Cataract and, Implant Surgery, Deputy Director General, S. Fyodorov Eye Microsurgery State Institution, Russia

Joe Redner Managing Director, Carl Zeiss Meditec Inc., Australia

Xudong Song Professor and Director, Cataract Surgical Center, Beijing Tongren Eye Center, China

Clement Tan Head and Senior Consultant at the Department of Ophthalmology, National University Hospital, Singapore

Mark Wilkins Consultant Ophthalmologist, Moorfields Eye Hospital, UK

14:30 - 15:50 > Company presentations 2Chair: Tina Wong, Senior Consultant, Singapore National Eye Centre

14:30 - 14:40 Company: pH Pharma Co. Ltd. Sanjeev Satyal Vice President, pH Pharma Co. Ltd.

14:40 - 14:50 Company: Ivantis Inc. Glen Burgess Managing Director Asia-Pacific, Ivantis Inc.

14:50 - 15:00 Company: Ellex Medical Lasers Tom Spurling Chief Executive Officer, Ellex Medical Lasers

15:00 - 15:10 Company: Eye Tech Care Dietrich Wolf Chief Executive Officer, Eye Tech Care

15:10 - 15:20 Company: Ace Vision Group, Inc. AnnMarie Hipsley Chief Executive Officer, Ace Vision Group, Inc.

15:20 - 15:30 Company: Avacta Life Sciences Amrik Basran Chief Scientific Officer, Avacta Life Sciences

15:30 - 15:40 Company: SinSa Labs Roger Beuerman Chief Financial Officer, SinSa Labs

15:40 - 15:50 Discussion


15:50 - 16:15 > The future of anti-microbials: Enough of our -cins? Chair: Donald Tan Professor, Singapore National Eye Center, Singapore

Panellists: Paul Anantharajah Tambyah Senior Consultant, Division of Infectious Diseases, National University of Singapore, Singapore

Roger Beuermann Professor, Ophthalmology, Cell Biology and Anatomy, Louisiana State University Eye Center, New Orleans, LA and Singapore Eye Research Institute, Singapore

David Chang Clinical Professor, University of California, San Francisco, USA

Xiaofeng Lin Professor and deputy director, Zhongshan Ophthalmic Center, Sun Yat-Sen University, China

16:15 - 16:40 > Coffee break

16:40 - 17:10 > Will laser refractive surgery bring a smile to Asian ophthalmologists?

Chair: Jodhbir Singh Mehta Associate Professor, Head and, Senior Consultant of Corneal and External Eye Disease Department, Singapore National Eye Center, Singapore

Panellists: Marcus Ang Consultant and Assistant Professor, Singapore National Eye Center, Singapore

Joe Redner Managing Director, Carl Zeiss Meditec Inc., Australia

Mark Wilkins Consultant Ophthalmologist, Moorfields Eye Hospital, UK

Marcos Zamorano Global Franchise Director, Laser Surgery Portfolio, Global Commercial Head, EFAs, Alcon, USA

Frank Ziemer President and Chief Executive Officer, Ziemer Ophthalmic Systems, Switzerland

17:10 - 17:25 > A view from the top: Ophthalmic innovation Keith Barton interviews Flemming Ornskov Chief Executive Officer, Shire Plc., USA

17:25 - 17:30 > Conclusion

17:30 - 19:30 > Cocktail reception


Pertinent topics to our industry and small companies showing what it takes to bring products to market and to treat patients.

Leonard Borrmann Divisional Vice President, R&D, Abbott

Turn back time European Forum 2016: Copenhagen

Our most recent Ophthalmology Futures European Forum, held in September 2016 in Copenhagen, was a huge success with an audience of over 350 industry professionals. The programme included 23 private company presentations including our popular Shark Tank and a View from the Top provided by the global CEO's of Alcon and Shire and the US CEO of Santen, moderated by James Mazzo.

The 2017 European Forum will take place in Lisbon, Portugal on 05 October. For more information and to register please visit: ophthalmology-futures.com

“Your long-standing support for us via Ophthalmology Futures Forum was a tremendous

podium for SalutarisMD getting our message out about episcleral brachytherapy.Our funding only came about because of, in part, Ophthalmology Futures Forum. Thank you!”

Laurence Marsteller Chief Executive Officer, Salutaris Medical Devices

“Many of the things that we see here are going to be making a difference in the lives of patients in five to seven years from now.”

Robert Warner Global Franchise Head, Vision Care, Alcon


Advisors• Laurent Attias Senior Vice

President, Head of Strategy, BD&L and Market Access, Alcon, USA

• Leonard Borrmann Divisional Vice President Research and Development, Abbott, USA

• Emmett Cunningham Partner with Clarus Ventures LLC, USA

• Eugene de Juan Founder, ForSight Labs and Jean Kelly Stock Distinguished Chair in Ophthalmology, University of California, San Francisco, USA

• Tom Dunlap Supervisory Board Member, i-Optics BV. Executive Vice President, Sand Hill Consulting Associates, USA

• Malvina Eydelman Director, Division of Ophthalmic and Ear, Nose and Throat Devices ODE/CDRH/FDA, USA

• Steven Fang Executive Director and Chief Executive Officer, Capbridge, Singapore

Organising committee• Keith Barton Consultant Ophthalmologist,

Moorfields Eye Hospital, UK

• Donald Budenz Professor and Chairman, Department of Ophthalmology, University of North Carolina at Chapel Hill, USA

• Kuldev Singh Associate Professor, Head and Senior Consultant of Corneal and External Eye Disease Department, Singapore National Eye Center, Singapore

• Chelvin Sng Consultant and Assistant Professor, National University Hospital, Singapore

Operational team• Melissa Murphy Operational Director,

Vision Futures Limited, London, UK

• Bhavika Tailor Programme Manager, Vision Futures Limited, London, UK

• Akira Kurokawa Chief Executive Officer and President Santen Pharmaceutical Co.

• James V. Mazzo Global President Ophthalmic Devices, Carl Zeiss Meditec, USA

• Calvin Roberts Executive Vice President and Chief Medical Officer at Bausch+Lomb, USA

• Brent Saunders Chief Executive Officer and President, Allergan, USA

• Baldo Scasselati Sforzolini Senior Vice President of Clinical Development, Allergan, USA

• Naveed Shams President and Chief Executive Officer, Santen Inc., USA

• Naveed Siddiqi Partner, Edmond de Rothschild Investment Partners, UK

• John Wilkinson Director of Devices, Medicines and Healthcare Products Regulatory Agency, UK

• Fay Xing Partner, Wuxi Healthcare Ventures, China

Programme advisory committee• Paul Rosen Consultant Ophthalmic

Surgeon Oxford Radcliffe Hospital NHS Trust and Senior Lecturer, University of Oxford, UK

• José-Alain Sahel Director, Vision Institute and Professor of Ophthalmology at Pierre and Marie Curie University Medical School, Paris; and Cumberlege Professor of Biomedical Science, University College London, UK

• Sanny Jiang Honorary Clinical Fellow at Moorfields Eye Hospital and Senior Research Associate at University College London Institute of Ophthalmology, UK

• Julian Stevens Consultant Ophthalmic Surgeon, Moorfields Eye Hospital, UK

• Donald Tan Medical Director of the Singapore National Eye Centre (SNEC), Professor of Ophthalmology, National University of Singapore, Academic Chair, Ophthalmology Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore

• Tien Yin Wong Medical Director, Singapore National Eye Center, Singapore

• Ike Ahmed Division Head, Ophthalmology, Trilium Health Partners, Assistant Professor, University of Toronto, Clinical Assistant Professor, University of Utah, USA

• Jorge Alio Professor and Chairman of Ophthalmology, Miguel Hernandez University, Alicante, President, Vissum Corporation, Spain

• Gerd Auffarth Chairman, Department of Ophthalmology, University of Heidelberg, Germany

• Francesco Bandello Full Professor and Chairman Department of Ophthalmology, Ospedale San Raffaele of Milan, Italy

• Beatrice Cochener Professor and Chairman, Ophthalmology Department, University Hospital Brest, France

• Paul Chew Professor of Ophthalmology, National University of Singapore, Singapore

• Jack Holladay Clinical Professor of Ophthalmology at Baylor College of Medicine Houston, USA

• Frank Holz Director and Chairman Universitäts-Augenklinik Bonn, University of Bonn, Germany

• Jost Jonas Professor of Ophthalmology, Medical Faculty Mannheim, University of Heidelberg, Germany

• Sir Peng Khaw Professor of Glaucoma and Ocular Healing, Director National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital and UCL Institute of Ophthalmology, UK

• Richard Lindstrom Founder and Attending Surgeon, Minnesota Eye Consultants, Adjunct Professor Emeritus, University of Minnesota, Past President, ASCRS, ISRS\AAO; IIIC, IRSC, Chief Medical Editor, Ocular Surgery News, USA

• Anat Loewenstein Vice Dean, Sackler Faculty of Medicine, Tel Aviv University and Chairman of Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Israel

• Boris Malyugin Chief of Department of Cataract and Implant Surgery, Deputy Director General, S. Fyodorov Eye Microsurgery Complex State Institution, Russia


> A

• Jonathan Agmon Partner, Head Singapore Office, Soroker Agmon Nordman, Singapore

• Jorge Alio Professor and Chairman of Ophthalmology, University of Alicante and University Miguel Hernandez de Elche, Spain

• Marcus Ang Consultant and Assistant Professor, Singapore National Eye Center, Singapore

> B

• Keith Barton Consultant Ophthalmologist, Moorfields Eye Hospital, UK

• Danny Belkin Technology Development and Commercialisation Director, Singapore Eye Research Institute, Singapore

• Miguel Bernabeu Global Head Market Access, Pricing and HEOR, Alcon Laboratories, Inc., USA

• Roger Beuermann Professor, Ophthalmology, Cell Biology and Anatomy, Louisiana State University Eye Center, New Orleans, LA and Singapore Eye Research Institute, Singapore

• Duncan Bishop Programme Director, Cambridge Consultants Ltd., UK

• Glen Burgess Managing Director Asia-Pacific, Ivantis Inc., Australia

> C

• David Chang Clinical Professor, University of California, San Francisco, USA

• Yan Cheng Chief Medical Officer of Global Clinical Research, Chengdu Kanghong Biotechnology Co. Ltd., China

• Caroline Chee Head and Senior Consultant for Surgical Retina, National University Hospital, Singapore

• Soon-Phaik Chee Senior Consultant and Head of Cataract and Ocular Inflammation and Immunology Service, Singapore National Eye Center, Singapore

> E

• Peter England Global Product Director, Surgical Glaucoma, Alcon, USA

> F

• Steven Fang Executive Director and Chief Executive Officer, Capbridge, Singapore

> H

• Takashi Hibi Head of Global Business Development at Santen Pharmaceutical Co. Ltd., Japan

• Chuck Holmes Director, Strategic Marketing, Bayer, USA

> K

• Miriam Kenrick Senior Director, International Strategic Marketing, Ophthalmology (Glaucoma), Allergan, UK

> L

• Timothy Lai Honorary Clinical Associate Professor, Department of Ophthalmology and Visual Sciences, Coordinator of the Medical Retina and Uveitis service, Hong Kong Eye Hospital, China

• Xiaoxin Li Professor and Director, People Eye Research Institute, Peking University and, Director, Ministry of Health State Key Laboratory for Trauma and Repairing, China

• Xiaofeng Lin Professor and Deputy Director, Zhongshan Ophthalmic Center, Sun Yat-Sen University, China

• XiangQian Lin Founder and General Partner, ESCO Ventures, Singapore

• Lin Lu Professor and Director, Fundus Disease Center, Zhongshan Ophthalmic Center, Sun Yat-sen University, China

> M

• Boris Malyugin Professor of Ophthalmology, Department of Cataract and Implant Surgery, Deputy Director General, S. Fyodorov Eye Microsurgery State Institution, Russia

• John Marshall Professor of Ophthalmology, Institute of Ophthalmology, University College London, UK

• Jodhbir Singh Mehta Associate Professor, Head and Senior Consultant of Corneal and External Eye Disease Department, Singapore National Eye Center, Singapore

• Steven Myint Adjunct Professor at Duke-National University Singapore in the Center for Technology, Enterprise and Development, Singapore

List of speakers and affliations


> N

• Mike Neilon Vice President, Glaukos Corporation, USA

• Ken Noonan Chief Executive Officer, Lightstone Ventures Pte. Ltd., Singapore

> O

• Jeong Shing Ong Investment Director, VentureCraft, Singapore

• Flemming Ornskov Chief Executive Officer, Shire Plc., USA

> P

• Ki Ho Park Professor of Ophthalmology, Seoul National University, South Korea

• Thong Yuen Poon Advisor and Mentor, Venturecraft Group, Zicom MedTacc Pte. Ltd., Singapore

> R

• Joe Redner Managing Director, Carl Zeiss Meditec Inc., Australia

• Paisan Ruamviboonsuk Assistant Director, Rajavithi Hospital and President of the Royal College of Ophthalmologists, Thailand

> S

• Leopold Schmetterer Professor of Ophthalmology and Head of Ocular Imaging, Singapore Eye Research Institute, Singapore

• Naveed Shams Head of Global Research and Development, Chief Scientific Officer, Senior Corporate Officer, Santen Pharmaceutical Co. Ltd., USA

• Chelvin Sng Consultant and Assistant Professor, National University Hospital, Singapore

• Xudong Song Professor and Director, Cataract Surgical Center, Beijing Tongren Eye Center, China

• Xinghuai Sun Professor and President, Eye and ENT Hospital, Fudan University and, Director, Department of Ophthalmology, Shanghai Medical School, Fudan University, China

> T

• Paul Anantharajah Tambyah Senior Consultant, Division of Infectious Diseases, National University of Singapore, Singapore

• Clement Tan Head and Senior Consultant at the Department of Ophthalmology, National University Hospital, Singapore

• Donald Tan Professor, Singapore National Eye Center, Singapore

• Theodore Tan Managing Director, The Biofactory, Singapore

• Akihiro Tsujimura President and Chief Executive Officer, Executive Corporate Officer, Santen Pharmaceutical Co. Ltd., USA

• Adnan Tufail Consultant Ophthalmologist, Moorfields Eye Hospital, UK

> W

• Ningli Wang Professor and Director, Beijing Tongren Eye Center, Director, Beijing Eye Research Institute, Director, Beijing College of Ophthalmology, Capital Medical University and, Secretary of the Party Committee and Vice President, Beijing Tongren Hospital, China

• Mark Wilkins Consultant Ophthalmologist, Moorfields Eye Hospital, UK

• Tien Yin Wong Medical Director, Singapore National Eye Center, Singapore

• Tina Wong Senior Consultant, Singapore National Eye Centre, Singapore

> X

• Fay Xing Partner, Wuxi Healthcare Ventures, China

> Y

• Tetsuya Yamamoto Professor and Chairman, Department of Ophthalmology and Director of Glaucoma Service, Gifu University School of Medicine, Japan

• Mingbin Yu Vice President, Sun Yat-Sen University and, Professor, Glaucoma Service, Zhongshan Ophthalmic Center, China

> Z

• Marcos Zamorano Global Franchise Director, Laser Surgery Portfolio, Global Commercial Head, EFAs, Alcon, USA

• Eli Zangvil Global Brand Medical Director, Novartis, Switzerland

• Danying Zheng Professor, Deputy Director, Department of Ophthalmology and Optometry, Zhongshan Ophthalmic Center, Sun Yat-Sen University, China and Optometry, Zhongshan Ophthalmic Center, Sun Yat-Sen University, China

• Frank Ziemer President and Chief Executive Officer, Ziemer Ophthalmic Systems, Switzerland


An Ophthalmologist driven forum of corporate leaders, financiers, regulators, clinicians and scientists gathered to facilitate innovative

ophthalmic product development and improve eye care delivery.

Supporting improved ocular health

“A meeting where we bring together innovators, ophthalmologists, venture capitalists, pharmaceutical and device manufacturers as well as regulators and market analysts.”

Kuldev Singh, Professor of Ophthalmology and Director of Glaucoma Service, Stanford

Supported charities

Programme - ophthalmology-futures.com€¦ · 3 Ophthalmology Futures Asia Forum 2017Singapore...

Documents

Transcript of Programme - ophthalmology-futures.com€¦ · 3 Ophthalmology Futures Asia Forum 2017Singapore...